Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. HRTS: which is better?

Bottom line

XLV vs HRTS: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and HRTS (Tema Heart & Health ETF) share a meaningful slice of their top holdings — about 57% by weight.

XLV is cheaper at 0.08% vs 0.75% — a difference of $67 a year per $10,000 invested.

Over one year, HRTS returned +23.6% vs +14.5% for XLV.

Updated Nov 19, 2026

XLV vs HRTS side by side

XLVHRTS
TypeETFETF
Fund familySPDR (State Street)Innovator
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%0.75%
Annual cost per $10k$8$75
10-yr cost on $10k (prospectus)$103$1,168
Max front loadNoneNone
12b-1 fee0.02%0%
1-yr return+14.5%+23.6%
5-yr return (annualized)+8.1%—
10-yr return (annualized)+9.8%—
Best quarter+14.5%+15.8%
Worst quarter−12.7%−12.4%
Net assets (fund)$40.6B$51.9M
Number of holdings6545
Portfolio turnover2%4%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXLVHRTSDifference
2025+14.5%+23.6%−9.1%
2024+2.5%+3.6%−1.1%

Source: Fund prospectus bar charts

Holdings overlap

15 of XLV's top 25 holdings also appear in HRTS's top 25.

Shared top holdings
HoldingXLVHRTS
Eli Lilly & Co16.51%11.52%
Johnson & Johnson10.64%3.59%
AbbVie Inc7.74%2.40%
UnitedHealth Group Inc6.57%5.24%
Merck & Co Inc5.52%4.27%
Amgen Inc3.40%1.91%
Thermo Fisher Scientific Inc3.24%3.97%
Abbott Laboratories2.75%2.61%
Gilead Sciences Inc2.73%3.43%
Vertex Pharmaceuticals Inc2.19%2.93%
Danaher Corp2.09%2.66%
Bristol-Myers Squibb Co2.05%2.09%
Medtronic PLC1.75%1.88%
McKesson Corp1.58%1.71%
Regeneron Pharmaceuticals Inc1.08%1.67%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

HRTS top 10

  1. Eli Lilly & Co — 11.52%
  2. UnitedHealth Group Inc — 5.24%
  3. Novo Nordisk A/S — 5.24%
  4. Roche Holding AG — 4.50%
  5. Merck & Co Inc — 4.27%
  6. AstraZeneca PLC — 4.00%
  7. Thermo Fisher Scientific Inc — 3.97%
  8. Johnson & Johnson — 3.59%
  9. Gilead Sciences Inc — 3.43%
  10. Novartis AG — 3.38%

FAQ

What is the difference between XLV and HRTS?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and HRTS (Tema Heart & Health ETF) share a meaningful slice of their top holdings — about 57% by weight. XLV is cheaper at 0.08% vs 0.75% — a difference of $67 a year per $10,000 invested.
Which is cheaper, XLV or HRTS?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and HRTS?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.